1. Yanase F, Naorungroj T, Bellomo RJB (2020): Glycocalyx damage biomarkers in healthy controls, abdominal surgery, and abdominal surgery sepsis: a scoping review. Biomarkers 25: 425-435.
2.
Zeng Z, Shi Z, Li X (2023): Comparing different scoring systems for predicting mortality risk in preterm infants: a systematic review and network meta-analysis. Front Pediatr 11: 1287774.
3.
Liu Z, Sun Z, Hu H, et al. (2024): Development and validation of a prospective study to predict the risk of readmission within 365 days of respiratory failure: based on a random survival forest algorithm combined with COX regression modeling. BMC Pulm Med 24: 82.
4.
Chen L, Qi X, Li R, et al. (2019): Injection of immunoglobulin in the treatment process of children with severe pneumonia. Pak J Med Sci 35: 940-944.
5.
Li J, Wu H, Zhang J (2022): Efficacy of phentolamine combined with ambroxol aerosol inhalation in the treatment of pediatric severe pneumonia and its effect on serum IL-10 and CRP levels. Transl Pediatr 11: 33-40.
6.
Ge L, Xun C, Li W, et al. (2021): Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-612. J Nanobiotechnology 19: 380.
7.
Zhang GL, Sun ML, Zhang XA (2021): Exercise-induced adult cardiomyocyte proliferation in mammals. Front Physiol 12: 729364.
8.
Jiang Q, Wang Q, Tan S, et al. (2023): Effects of plasma-derived exosomal miRNA-19b-3p on Treg/T helper 17 cell imbalance in Behçet’s uveitis. Invest Ophthalmol Vis Sci 64: 28.
9.
Zhu W, Gui W, Lin X, et al. (2021): Maternal undernutrition modulates hepatic MicroRNAs expression in the early life of offspring. Exp Cell Res 400: 112450.
10.
Nahand JS, Karimzadeh MR, Nezamnia M, et al. (2020): The role of miR-146a in viral infection. IUBMB Life 72: 343-360.
11.
Vaz CO, Hounkpe BW, Oliveira JD, et al. (2023): MicroRNA 205-5p and COVID-19 adverse outcomes: Potential molecular biomarker and regulator of the immune response. Exp Biol Med (Maywood) 248: 1024-1033.
12.
Jia Z, Sun Q, Zheng Y, et al. (2023): The immunogenic involvement of miRNA-492 in mycoplasma pneumoniae infection in pediatric patients. J Pediatr 99: 187-192.
13.
Savino F, Gambarino S, Dini M, et al. (2023): Peripheral blood and nasopharyngeal swab MiRNA-155 expression in infants with respiratory syncytial virus infection. Viruses 15: 1668.
14.
Bukhari MMM, Mir I, Idrees M, et al. (2020): Role of microRNAs in establishing latency of human immunodeficiency virus. Crit Rev Eukaryot Gene Expr 30: 337-348.
15.
Ni J, Tian W, Liang S, et al. (2021): Promoter methylation-mediated silencing of the MiR-192-5p promotes endometrial cancer progression by targeting ALX1. Int J Med Sci 18: 2510-2520.
16.
Akpınar K, Aslan D, Fenkçi SM, et al. (2022): miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy. Diagnosis (Berlin, Germany) 9: 499-507.
17.
Zou P, Zhu M, Lian C, et al. (2019): miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44. Sci Rep 9: 19619.
18.
Ren FJ, Yao Y, Cai XY, et al. (2021): Emerging role of MiR-192-5p in human diseases. Front Pharmacol 12: 614068.
19.
Liu Y, Ren H, Guo J, et al. (2021): Effect of continuous nursing on nursing quality and patient quality of life and satisfaction among children with pneumonia. J Int Med Res 49: 300060521993691.
20.
Kortz TB, Herzel B, Marseille E, et al. (2017): Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis. BMJ Open 7: e015344.
21.
Wang S, Li L, Wang W (2023): Knockdown of Slfn5 alleviates lipopolysaccharide-induced pneumonia by regulating Janus kinase/signal transduction and activator of transcription pathway. J Thorac Dis 15: 6708-6720.
22.
An L, Yin F (2021): MiR-192-5p suppresses M1 macrophage polarization via epiregulin (EREG) downregulation in gouty arthritis. Tissue Cell 73: 101669.
23.
Fu XL, He FT, Li MH, et al. (2023): Up-regulation of miR-192-5p inhibits the ELAVL1/PI3K axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy. Diabet Med 40: e15077.
24.
Zhao L, Wang B, Sun L, et al. (2021): Association of miR-192-5p with atherosclerosis and its effect on proliferation and migration of vascular smooth muscle cells. Mol Biotechnol 63: 1244-1251.
25.
Hu Y, Yu Y (2020): Dysregulation of miR-192-5p in acute pancreatitis patients with nonalcoholic fatty liver and its functional role in acute pancreatitis progression. Biosci Rep 40: BSR20194345.
26.
Xu J, Zou J, Wu L, et al. (2020): Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma. Sci Rep 10: 16584.
27.
Yang T, Mei Q, Fang X, et al. (2022): Clinical value of metagenomics next-generation sequencing in bronchoalveolar lavage fluid for patients with severe hospital-acquired pneumonia: A nested case-control study. Infect Drug Resist 15: 1505-1514.
28.
Flammang I, Reese M, Yang Z, et al. (2020): Tumor-suppressive miR-192-5p has prognostic value in pancreatic ductal adenocarcinoma. Cancers (Basel) 12: 1693.
29.
Fakılı F, Işık AF, Kahraman D, et al. (2023): The profiling of apoptosis-associated microRNA expressions of the lung adenocarcinoma. Thorac Res Pract 24: 123-130.
